Status:
COMPLETED
Special Drug Use-Results Survey of Lipitor Tablets
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
Brief Summary
This study is to evaluate the controlling effect of atrovastatin on plasma lipid to achieve the category-specific targeted lipid levels.
Detailed Description
To confirm the low-density lipoprotein cholesterol (LDL-C)-lowering effect of 24 weeks of treatment with Lipitor®(Generic Name : atorvastatin calcium) Tablets and determine the rate of achievement of ...
Eligibility Criteria
Inclusion
- Patients with hypercholesterolemia who have not achieved the category-specific target lipid level
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
24050 Patients enrolled
Trial Details
Trial ID
NCT01446679
Start Date
September 1 2010
End Date
March 1 2012
Last Update
February 21 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku, Japan
2
Chūbu, Japan
3
Hokkaido, Japan
4
Kansai, Japan